Regeneron tops Q2 profit estimates

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Wednesday, Regeneron Pharmaceuticals has topped its Q2 profit estimates, driven by robust sales of the eczema treatment Dupixent, as well as higher revenues related to its Sanofi and Bayer collaboration.
Back to articles

Actual Topics

Wed, 05 Aug 2020 13:35:32 GMT

Thomson Reuters Q2 profit beats forecasts

Thomson Reuters posted a higher-than-anticipated Q2 profit on Wednesday, reaffirming its 2020 outlook in the face of the global market uncertainty.

Wed, 05 Aug 2020 11:31:28 GMT

Clearwater Analytics considers $2B sale

The software firm Clearwater Analytics is considering a sale worth around $2B, including debt, while WCAS has hired an investment lender to review potential strategic options for the privately-owned company.

Subscribe to "Fundamental Analysis" feed

Subscribe
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request)
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request).
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.